Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Parasomnias × nabiximols × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 9 Neoplasms 9 Marijuana Abuse 5 Cancer Pain 4 Glioblastoma 2 Squamous Cell Carcinoma of Head and Neck 1 Signs and Symptoms 1 Recurrence 1 Parasomnias 1 Pancreatic Neoplasms 1 Neuralgia 1 Nausea 1 Multiple Sclerosis 1 Mouth Neoplasms 1 Marijuana Use 1 Diabetes Mellitus 1 Chronic Pain 1 Cachexia 1 Breast Neoplasms 1 Brain Neoplasms 1 Anxiety Disorders 1 Anorexia 1 Advanced Malignant Solid Tumor 1 Advanced Cancer 1 1- Cancer Patients During Chemotherapy Treatment 1

Interventions

Surveys and Questionnaires 6 Melatonin 4 Yoga 2 Exercise 2 Control Groups 2 nabiximols 1 Walking 1 Ultraviolet Therapy 1 Tai Ji 1 Sugars 1 Respiration 1 Relaxation Therapy 1 Qigong 1 Modafinil 1 Minocycline 1 Mindfulness 1 Massage 1 Exercise Movement Techniques 1 Dronabinol 1 Cannabidiol 1 Breathing Exercises 1 Autogenic Training 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03948074 2025-09-10

CAFCARS

British Columbia Cancer Agency

Phase 2 Completed

Anxiety Disorders, Nausea, Pain, Parasomnias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡